MTPConnect

We are Australia's Life Sciences Innovation Accelerator championing the continuing growth of Australia's vibrant medical products sector.

[AAMRI @AAMRI_Aus]

📣 Calling Vic Early-Mid Career Researchers! We're excited to offer YOU a spot in an industry-informed commercialisation training program, designed to build knowledge and skill in the pre-seed stage of your research journey. Places for this FREE training are limited - register today! https://t.co/PoNtioBr24

The training will culminate in a pitch night to industry providing a genuine platform to advance your commercialisation efforts!

This exciting new program is led by AAMRI Vic in partnership with @MTPConnect_AUS and @Swinburne, and funded by @VicGovAu's Dept. of Jobs, Skills, Industry and Regions.

#commercialisation #medicalresearch #EMCRs #training #partnership

[MTPConnect @MTPConnect_AUS]

👨🏻‍🔬💡💊 @CSL was awarded a #REDI Fellowship to embed Dr Samuel Harley, a #research #translation & #commercialisation professional from @QIMRB_Institute, within its Global Research Innovation team. Find out more about his placement with CSL in 🇦🇺🏖️ & 🇨🇭🌄 https://t.co/Z23IWGhBvS

[MTPConnect @MTPConnect_AUS]

👁️👨‍💻👩‍⚕️@ellexmedical - a leading ophthalmic equipment manufacturer - was awarded a #REDI Fellowship for A/Prof Ivan Lee from @UniversitySA STEM to address challenges in image processing in the development of a new device for glaucoma treatment. Read more https://t.co/uI8HWZ0ajY

[MTPConnect @MTPConnect_AUS]

.@QUT's Cardiovascular Engineering Lab has developed a new way to diagnose clogged arteries in people with diabetes & heart disease. Find out why funding from our Targeted Translation Research Accelerator #TTRA program was crucial for this project. 💡💰❤️💻https://t.co/V8at2MZJSy

[MTPConnect @MTPConnect_AUS]

Each year over our #REDI initiative, 20 pharma & medtech researchers, clinicians & innovators from around 🇦🇺 were awarded short-term industry placements via @redi_qut Bridge & BridgeTech Industry Fellowships to increase skills & knowledge. Find out more. https://t.co/rrtHNuIwUP

[MTPConnect @MTPConnect_AUS]

📢ICYMI! Our TTRA Drugs & Devices accelerator funding opportunity closed 4 Nov, we wrapped up our North America medtech mission w special podcast, news, events & case study on @speedx & more! https://t.co/DZvhzWuK0U

[MTPConnect @MTPConnect_AUS]

📢Closing 4 Nov! EOIs for the Targeted Translation Research Accelerator (TTRA) Drugs & Devices from SMEs keen to commercialise innovative medical products to address cardiovascular disease & diabetes complications. Up to $1.5M available. https://t.co/3isWtfnXeK
@CSL @rochediaau

[MTPConnect @MTPConnect_AUS]

📢Our Oct newsletter is out! Our TTRA Drugs & Devices accelerator funding opportunity closes 4 Nov, we wrap up our North America medtech mission w special podcast, news, events & a case study on @speedx & more! https://t.co/fJp6x0Fl9b

[MTPConnect @MTPConnect_AUS]

With the Korean biotech delegation in Melbourne, our @belcher_jarrod was pleased to join the group from KHIDI & Yonsei University's K-NIBRT – on a visit to @MonashUni Parkville to discuss pharmaceutical sciences, mRNA research & workforce development! 🇰🇷🇦🇺https://t.co/NCpP0xiECw

[MTPConnect @MTPConnect_AUS]

🎧Special #MedTechConf podcast from N. America with @DMCM's Kylle Jordan, @MedicalAlley's Roberta Dressen, iYarn’s Lockie Cooke, @UniMelb's @DrLaurenAyton, Materia Health’s Dr Emily Zhen & major supporter, @Global_Vic’s Carolin McCaffrey. 🎧https://t.co/JIo0muM5dT

[MTPConnect @MTPConnect_AUS]

🎧In our special #MedTechConf podcast ep we hear from @DMCM's Kylle Jordan, @MedicalAlley's Roberta Dressen, iYarn’s Lockie Cooke, @UniMelb's @DrLaurenAyton, Materia Health’s Dr Emily Zhen & major supporter, @Global_Vic’s Carolin McCaffrey.
Stay tuned! 2/2🧵

[MTPConnect @MTPConnect_AUS]

🎧Tune into a special @MedTechCon 2024 podcast ep where our CEO @StuDignam catches up with some medtech movers & shakers during our Australian delegation’s visit to North America and find out why international connections can make the difference. 🇦🇺🌏 1/2 🧵

[MTPConnect @MTPConnect_AUS]

Great news from @ArgenicaT 👇

[Argenica Therapeutics @ArgenicaT]

Earlier today, Argenica Therapeutics announced the United States #FDA has granted its second neuroprotective drug candidate, ARG-006, #ODD and #RPDD for the treatment of Hypoxic Ischaemic Encephalopathy (HIE) in newborn term infants.

Read more ➡ https://t.co/pPGpLYhuAI

[MTPConnect @MTPConnect_AUS]

Great to see @AusBiotech CEO Rebekah Cassidy & our CEO @StuDignam Dignam at #AusBiotech2024 highlighting the importance of Australia’s 1st National Biotech & Medtech Development & Commercialisation Summit, coming up in Canberra on 19 Nov 2024. Let's supercharge the 'D' in R&D!

[MTPConnect @MTPConnect_AUS]

Great to have some of our team taking part in the @program_bridge Symposium in Melbourne - which aims to boost the commercial outputs of Australian pharmaceutical research. MTPConnect SA's @DanaBell22 shared her insights on making industry connections with the cohort.

[MTPConnect @MTPConnect_AUS]

Delighted to be hosting the Korean delegation of health officials in Sydney and Melbourne for meetings and site visits this week ahead of #AusBiotech24, working with @Austrade. Building on our connection with Korean Health Industry Development Institute! 🫶

[MTPConnect @MTPConnect_AUS]

Excited to be part of this new program to equip early career researchers with commercialisation know-how & opportunities to partner with industry on medical innovations - so more make it from the lab to the patient. Our COO Lisa Dubé joined Hon. Natalie Hutchins MP at the launch!

[AAMRI @AAMRI_Aus]

📢 Vic’s next generation of medical and medtech researchers will be upskilled in research commercialisation and connect directly with industry thanks to a new real-world, collaborative training program led by the AAMRI VIC in partnership with @Swinburne and @MTPConnect_AUS 👇

[MTPConnect @MTPConnect_AUS]

We’re delighted to host the Korean delegation to @AusBiotech! The delegates visited @RandwickHealth in Sydney for site visits & presentations on genomics & cancer research. Korea is an increasingly important market & and hub for the #lifesciences sector in Australia. 🇦🇺🇰🇷👏🏼👏🏻���🧬

[MTPConnect @MTPConnect_AUS]

📢New case study! A #REDI Fellowship brought researcher Dr Emma Sweeney together with molecular diagnostic company @speedx, to develop new precision medicine treatment strategies for sexually transmitted superbug Mycoplasma genitalium. Find out more🧪 https://t.co/iNJr3bjOyG

[MTPConnect @MTPConnect_AUS]

👏Congratulations to @CORTICAL10, @MicrobioAus , and Resonait Medical Technologies for being selected for the new Biomedical AI Sprints Accelerator established by @ARMHubAus & @MTPConnect_AUS
More info...bit.ly/3UlcJze